Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
about
Gene Therapy for Pediatric Cancer: State of the Art and Future PerspectivesCyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging.Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disordersCombined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirusImproving the safety of cell therapy with the TK-suicide geneTargeted expression of suicide gene by tissue-specific promoter and microRNA regulation for cancer gene therapyGene therapy and targeted toxins for glioma.A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Delta24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapyRequirement of an integrated immune response for successful neuroattenuated HSV-1 therapy in an intracranial metastatic melanoma modelAdenoviral virotherapy for malignant brain tumorsArmed replicating adenoviruses for cancer virotherapy.Oncolytic viral therapy of malignant gliomaTheranostic potential of oncolytic vaccinia virus.Imaging of viral thymidine kinase gene expression by replicating oncolytic adenovirus and prediction of therapeutic efficacy.Gene therapy and targeted toxins for glioma
P2860
Q24792778-43E68FBC-590A-4184-8A20-672C9F362823Q33641230-54DACF99-6EEB-4E7F-B253-0713927F8124Q33985663-4DF1996C-5E96-4D57-BB76-2211E1EB2B7AQ34063140-EE517A4B-967C-4BCA-82B8-6F47775586B7Q34124614-6E6CD469-6D74-4D1C-828A-E88ED56C7F40Q34477411-B2F8E258-98BD-4F5D-BB2F-A696FDF7DBD5Q35082459-3E3ABE9E-2706-4482-AC65-9772B3C33847Q35118933-409DB37C-96E8-431E-94E6-DE9C6541E9F8Q36387946-0DEB5920-5EFF-4DB9-8FB0-D7DE1700C382Q37141874-2D5169EA-27D1-49FF-A370-73285C64744BQ37223846-F408BAF4-8E77-4381-9618-E5C1450E9DDCQ37386616-38ADBFE6-C1FA-431B-A56F-836601B513FDQ37533665-BB6ED7FE-C4CE-424E-A4CB-AC6D3E2DBCCCQ39628429-44AFE25A-B406-483D-9BB7-216F4C1550EFQ39923461-AFD30629-05DB-4B12-A356-12439FCB0F99Q57006162-186495CE-CA07-4118-9124-2BF99A9691D4
P2860
Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Treatment of malignant gliomas ...... implex virus-thymidine kinase.
@ast
Treatment of malignant gliomas ...... implex virus-thymidine kinase.
@en
type
label
Treatment of malignant gliomas ...... implex virus-thymidine kinase.
@ast
Treatment of malignant gliomas ...... implex virus-thymidine kinase.
@en
prefLabel
Treatment of malignant gliomas ...... implex virus-thymidine kinase.
@ast
Treatment of malignant gliomas ...... implex virus-thymidine kinase.
@en
P2093
P1433
P1476
Treatment of malignant gliomas ...... implex virus-thymidine kinase.
@en
P2093
P304
P407
P577
2001-12-01T00:00:00Z